Anchor Capital Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$863K Buy
746
+25
+3% +$29.5K 0.03% 179
2026
Q2
$865K Hold
721
– – 0.02% 182
2026
Q1
$663K Hold
721
– – 0.02% 186
2025
Q4
$775K Sell
721
-38
-5% -$36.3K 0.02% 188
2025
Q3
$579K Sell
759
-8
-1% -$5.95K 0.02% 199
2025
Q2
$598K Hold
767
– – 0.02% 198
2025
Q1
$633K Hold
767
– – 0.02% 191
2024
Q4
$592K Hold
767
– – 0.02% 204
2024
Q3
$680K Hold
767
– – 0.02% 191
2024
Q2
$694K Hold
767
– – 0.02% 185
2024
Q1
$597K Hold
767
– – 0.02% 195
2023
Q4
$447K Hold
767
– – 0.01% 205
2023
Q3
$412K Hold
767
– – 0.01% 221
2023
Q2
$360K Sell
767
-708
-48% -$297K 0.01% 231
2023
Q1
$507K Hold
1,475
– – 0.01% 217
2022
Q4
$540K Hold
1,475
– – 0.01% 216
2022
Q3
$477K Hold
1,475
– – 0.01% 216
2022
Q2
$478K Hold
1,475
– – 0.01% 222
2022
Q1
$422K Hold
1,475
– – 0.01% 232
2021
Q4
$407K Hold
1,475
– – 0.01% 233
2021
Q3
$341K Sell
1,475
-50
-3% -$12.3K 0.01% 237
2021
Q2
$350K Sell
1,525
-25
-2% -$5.02K 0.01% 238
2021
Q1
$290K Hold
1,550
– – 0.01% 245
2020
Q4
$262K Sell
1,550
-10
-0.6% -$1.49K 0.01% 241
2020
Q3
$231K Hold
1,560
– – 0.01% 244
2020
Q2
$256K Sell
1,560
-10
-0.6% -$1.54K 0.01% 232
2020
Q1
$218K Sell
1,570
-30
-2% -$4.12K 0.01% 230
2019
Q4
$210K Buy
+1,600
New +$185K ﹤0.01% 249
2019
Q2
– Sell
-1,750
Closed -$227K – 249
2019
Q1
$227K Hold
1,750
– – ﹤0.01% 240
2018
Q4
$203K Buy
+1,750
New +$195K 0.01% 264

Other funds holding LLY

Anchor Capital Advisors's LLY Position: Q3 2026 in Review

Anchor Capital Advisors increased its Eli Lilly (LLY) stake by 3.5% in Q3 2026, buying an estimated $29.5K and bringing the position to 746 shares worth $863K. The position accounts for 0.03% of the portfolio, ranked #179.

Anchor Capital Advisors first reported a position in LLY in Q4 2018 and has held it in 30 quarters since. The position peaked at $865K in Q2 2026. 4,631 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Anchor Capital Advisors held 746 shares of Eli Lilly worth $863K as of Q3 2026.
  • Anchor Capital Advisors bought 25 Eli Lilly shares in Q3 2026, an estimated $29.5K.
  • Eli Lilly made up 0.03% of Anchor Capital Advisors's portfolio in Q3 2026, its #179 holding.
  • Anchor Capital Advisors first reported a position in Eli Lilly in Q4 2018 and has held it in 30 quarters since.
  • Anchor Capital Advisors's Eli Lilly position peaked at $865K in Q2 2026.
  • 4,631 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Anchor Capital Advisors's 13F filing for Q3 2026, filed 5 Nov 2026.